L-Ornithine L-Aspartate (LOLA) is a compound that combines two amino acids, ornithine and aspartate, and is primarily used in the medical field to support liver function and manage hepatic encephalopathy, a condition that can occur in liver disease. Ornithine is involved in the urea cycle, which helps detoxify ammonia, a byproduct of protein metabolism that can accumulate and cause neurological symptoms if not properly eliminated. Aspartate, on the other hand, is involved in the synthesis of other amino acids and plays a role in energy production and cellular metabolism. Together, L-Ornithine L-Aspartate helps to enhance the liver’s ability to process ammonia, reducing its levels in the blood and alleviating symptoms of hepatic encephalopathy, such as confusion and cognitive impairment. Beyond its use in liver health, LOLA has been studied for its potential benefits in improving exercise performance and recovery. By supporting ammonia detoxification, it may help reduce exercise-induced fatigue and improve overall physical endurance. Additionally, LOLA is used in various clinical settings to support patients with liver conditions, including cirrhosis and chronic liver disease, by promoting better nitrogen balance and reducing the risk of complications associated with impaired liver function. Overall, L-Ornithine L-Aspartate is a valuable therapeutic agent in managing liver-related disorders and enhancing physical performance through its role in amino acid metabolism and ammonia detoxification.